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ABSTRACT
Objectives: To determine psychotropic drug prescription rates in nursing home residents with
dementia and to identify associations with the so far understudied psychosocial non-resident-related
factors.
Method: A cross-sectional, observational, exploratory design as part of PROPER I (PRescription
Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia). Participants
were 559 nursing home residents with dementia, 25 physicians, and 112 nurses in the Netherlands.
Psychotropic drug prescription, non-resident-related and known resident-related variables were
measured to operationalize the themes of our previous qualitative analysis.
Results: Fifty-six percent of residents were prescribed any psychotropic drug, 25% antipsychotics, 29%
antidepressants, 15% anxiolytics, and 13% hypnotics, with large differences between the units.
Multivariate multilevel regression analyses revealed that antipsychotic prescription was less likely with
higher physicians’ availability (odds ratio 0.96, 95% conﬁdence interval 0.93–1.00) and that
antidepressant prescription was more likely with higher satisfaction of nurses on resident contact
(odds ratio 1.50, 95% conﬁdence interval 1.00–2.25). Resident-related factors explained 6%–15% of
the variance, resident- and non-resident-related factors together 8%–17%.
Conclusion: Prescription rates for antipsychotics are similar compared to other countries, and
relatively low for antidepressants, anxiolytics, and hypnotics. Our ﬁndings indicate that improvement





Although psychotropic drugs (PDs) have only modest efﬁcacy
for treatment of neuropsychiatric symptoms (NPS), and can
cause severe side effects (Ballard & Waite, 2006; Knol et al.,
2008; Langballe et al., 2014; McCleery, Cohen, & Sharpley,
2014; Nelson & Devanand, 2011; Schneider, Dagerman, &
Insel, 2006; Seitz et al., 2013), these agents are widely pre-
scribed in nursing home residents with dementia. Worldwide,
66%–79% of nursing home residents are treated with any PD,
12%–54% with antipsychotics (APs), 28%–40% with antide-
pressants (ADs), 16%–29% with anxiolytics, and 15%–23%
with hypnotics (De Mauleon et al., 2014; Dutcher et al., 2014;
Maust, Langa, Blow, & Kales, 2016; Stevenson et al., 2010;
Vasudev et al., 2015; Zuidema, De Jonghe, Verhey, & Koop-
mans, 2011). In order to optimize prescription, it is relevant to
be aware of the current prescription rates, and it is of major
importance to know the correlates of the PD prescription, so
that those susceptible to change can be improved.
Several factors contributing to PD prescription have been
investigated, the most extensive of which were the resident-
related factors. In general, more severe NPS (De Mauleon
et al., 2014; Foebel et al., 2014; Gustafsson, Sandman, Karlsson,
Gustafson, & Lovheim, 2013; Kleijer et al., 2014; Maust et al.,
2016; Nijk, Zuidema, & Koopmans, 2009; Nishtala, McLachlan,
Bell, & Chen, 2010), comorbid psychiatric disorders (Kamble,
Chen, Sherer, & Aparasu, 2009; Larrayadieu et al., 2011; Nish-
tala et al., 2010), and less severe stage of dementia (Blass
et al., 2008; Nijk et al., 2009) are associated with higher pre-
scription rates. Non-resident-related factors are increasingly
being recognized as potential correlates. Higher staff distress
due to residents’ agitation (Zuidema et al., 2011) and factors
such as a larger facility (Kleijer et al., 2014), lower staff/resident
ratio (Kim & Whall, 2006; Testad et al., 2010; Zuidema et al.,
2011), and lower resident satisfaction of the number of staff,
of personal care, and of recreational activities (Kleijer et al.,
2014) are related to higher PD prescription. Also, qualitative
studies have sought to elucidate additional factors (Cohen-
Mansﬁeld et al., 2005; Cornege-Blokland, Kleijer, Hertogh, &
Van Marum, 2012; Smeets et al., 2014; Wood-Mitchell, James,
Waterworth, Swann, & Ballard, 2008) and underpinned the
need to explore the prescribing culture (Bonner et al., 2015).
These studies point at an important share of psychosocial non-
resident-related factors, including feeling powerless toward
NPS, previous prescribing experiences of physicians, communi-
cation among professionals and with family, educational level
of nurses, nursing home stafﬁng, and continuity in care. So far,
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these psychosocial factors have to our best knowledge not
been quantitatively studied. This study aims to obtain insight
into current prescription rates and to identify the so far under-
studied psychosocial non-resident-related factors.
Methods
Design and setting
This exploratory study is part of PROPER I (Van der Spek et al.,
2013). It has a cross-sectional, observational design and was
conducted between January and July 2012 in Dutch nursing
homes. In the Netherlands, nursing home locations are usually
part of larger long-term care organizations with speciﬁc
dementia special care units (DSCUs). DSCUs can be either
small- (5–10 residents) or regular-scale (10–30 residents). Pri-
mary responsible nurses are assigned to individual residents,
and physicians, mainly certiﬁed as elderly care physician, are
employed by the nursing home (Koopmans, Lavrijsen, Hoek,
Went, & Schols, 2010). We aimed for a sample size of 540 resi-
dents with dementia, with maximum contrast in prescription
rates, and their nurses and physicians (Van der Spek et al.,
2013). Therefore, we selected DSCUs based upon PD prescrip-
tion rates as reported in questionnaires previously distributed
among all Dutch elderly care physicians.
The local Medical Ethics Review Committee ‘CMO Regio Arn-
hem-Nijmegen’ rated the study [number 2012/226] and stated
that it was in accordance with the applicable Dutch rules con-
cerning review of research ethics committees and informed con-
sent. The study was conducted in accordance with the
Declaration of Helsinki (WorldMedical Association, 2013).
Measures
Table 1 shows all the measures included in this study.
Dependent variables
PDprescriptionwas grouped according to the Anatomical Thera-
peutic Chemical classiﬁcation into: APs (N05A), ADs (N06A), anx-
iolytics (N05B), and hypnotics (N05C) (Nordic Council on
Medicines, 1990). PD prescription was measured as PD prescrip-
tion at the day of assessment for treatment of NPS explained by
the presence of dementia, a sleep disorder or a delirium, and
excluding pro re nata use. The maximum time window between
the use of PDs and possibly related factors was six weeks.
Independent variables
Selection of measures. For operationalization of non-resi-
dent-related factors, we used results of the previously con-
ducted qualitative analysis of the PROPER I study (Smeets et
al., 2014). We opted to analyze speciﬁcally those (sub)scales
among the quantitative data, ﬁtting in the four themes con-
tributing to PD prescription, after critical review and consen-
sus among the co-authors: (1) Mindset, e.g. perceptions and
opinions of physicians and nurses toward the nature and
intensity of NPS and toward PDs, (2) Knowledge and experience
of physicians and nurses with regard to NPS and PDs, such as
the level of training and the number of years of employment,
(3) effective Communication and collaboration among health-
care professionals regarding NPS and PDs, and (4) External
possibilities/limitations, comprising stafﬁng issues, like sufﬁ-
cient time for the job, the number and continuity of nurses,
and issues related to living within a nursing home setting.
This led to the exclusion of variables regarding the use of psy-
chosocial interventions, physical environment, and satisfac-
tion of career perspective, of quality of care, and of unit
supervisor. We also included known resident-related varia-
bles. Moreover, the qualitative results indicated that factors
differ per class of PD, which compelled us to study the AP,
AD, anxiolytics, and hypnotics separately.
Resident-related factors. We collected data on age, sex,
length of stay at DSCU, and chart diagnosis of dementia as
categorized into Alzheimer’s dementia, vascular dementia,
mixed Alzheimer’s/vascular dementia, and other dementia
(including ‘not otherwise speciﬁed’).
We assessed the severity of NPS using the 12-item Neuro-
psychiatric Inventory Questionnaire (NPI-Q) (De Jonghe, Kat,
Kalisvaart, & Boelaarts, 2003; Kaufer et al., 2000). Symptoms
were grouped into clinically meaningful clusters or individual
symptoms, similar to this instrument’s Nursing Home version
(Zuidema et al., 2011). From these, we included only those
that were potential indications for a speciﬁc class of PDs
(Smalbrugge et al., 2008). For AP: psychosis (range 0–6, a
higher score reﬂecting higher severity), agitation (range 0–9),
and nighttime behavior (range 0–3); for AD: agitation, depres-
sion (range 0–3), anxiety (range 0–3); for anxiolytics: agitation
and anxiety; and for hypnotics: anxiety and nighttime behav-
ior. NPS were also assessed using the Cohen-Mansﬁeld Agita-
tion Inventory (CMAI) (De Jonghe & Kat, 1996; Zuidema, De
Jonghe, Verhey, & Koopmans, 2007), consisting of 29 agitated
behaviors, which we grouped into three clusters: physical
aggression (range 8–56, a higher score reﬂecting more fre-
quent occurrence), physically nonaggressive behavior (range
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MAS-GZ subscale ‘satisfaction of colleague contact’




Nurse/resident ratio during day
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Number of residents per DSCU
Number of different caregivers at DSCU
DSCU: dementia special care unit, NPI-Q: Neuropsychiatric Inventory Ques-
tionnaire, CMAI: Cohen-Mansﬁeld Agitation Inventory, SDCS: Strain in
Dementia Care Scale, MAS-GZ: Maastricht Work Satisfaction scale for
Healthcare, ADQ: Approaches to Dementia Questionnaire, CVFS: Compet-
ing Values Framework Scale.
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7–49), and verbally agitated behavior (range 4–28) (Zuidema
et al., 2007). Also for the CMAI, we included only clusters that
were potential indications: all three CMAI clusters for AP,
physical aggression and verbally agitated behavior for AD
and for anxiolytics, and none for hypnotics.
Non-resident-related factors. To operationalize nurses’ per-
ceptions and opinions, the Mindset, we used four measures.
The ﬁrst was the NPI-Q emotional distress scale which assesses
distress caused by NPS, according to the aforementioned clus-
ters. This resulted in the following ranges (higher score reﬂect-
ing higher distress): 0–10 for psychosis, 0–15 for agitation, and
0–5 for depression, anxiety, and nighttime behavior. The sec-
ond was the 27-item Strain in Dementia Care Scale (SDCS)
(Orrung Wallin, Edberg, Beck, & Jakobsson, 2013) that measures
nurses’ feelings with regard to caring for residents with demen-
tia (range 1–16, a higher score reﬂecting higher distress). The
third measure was the subscale ‘satisfaction of resident contact’
from the Maastricht Work Satisfaction Scale for Healthcare
(MAS-GZ) (Landeweerd, Boumans, & Nissen, 1996), consisting
of three items on mutual liking between residents and nurses
(range 1–5, a higher score indicating higher satisfaction). The
fourth was the 19-item Approaches to Dementia Questionnaire
(ADQ), which measures the attitude toward caring for people
with dementia (Lintern, 2001) (range 19–95, with a higher score
reﬂecting more positive attitude). To operationalize the Mindset
of physicians, we also used the ADQ.
For operationalization of nurses’ Knowledge and experience,
we used their profession, categorized into nursing assistant,
certiﬁed nursing assistant, or registered nurse, and the num-
ber of years employed at the current DSCU. For physicians,
we used the number of years working as a physician, and the
number of months working at the current DSCU.
We used two other MAS-GZ subscales to operationalize
nurses’ Communication and cooperation: ‘satisfaction of col-
league contact’, with items on mutual liking between nurses
and colleagues, and ‘satisfaction of clarity’, with items regard-
ing tasks in the job.
To assess stafﬁng issues of nurses within the External possi-
bilities/limitations theme, we used the 8-item Work Stress
Scale, an instrument on psychological stressors within health-
care (De Jonge, Landeweerd, & Nijhuis, 1995) (range 1–5, a
higher score reﬂecting more stress). Moreover, we used the 6-
item Competing Values Framework Scale (CVFS), which
assesses dominance in four organizational cultures (Scott-
Cawiezell, Jones, Moore, & Vojir, 2005; Van Beek & Gerritsen,
2010): clan (characterized by strong cohesion), adhocracy
(which can adapt quickly to changes), hierarchy (with struc-
ture and rules), and market (result-oriented) (range 0–18, a
lower score reﬂecting more dominancy). Furthermore, we
used the nurse/resident ratio during the day (morning, after-
noon, and evening) and during the night multiplied by 1000
to allow interpretation of the odds ratios, and the physician’s
availability in minutes per resident per week. Finally, we used
the number of residents per DSCU as a measure for commo-
tion within the nursing home setting, and, for assessing conti-
nuity in care, the total number of different caregivers (e.g.
nurses, supporting personnel) at the DSCU.
Procedures
Variables were either collected per individual resident (PD
prescription, resident characteristics, NPI-Q, and CMAI) or per
group of residents (all other variables) (Van der Spek et al.,
2013). Some data were retrieved by the researchers (PD pre-
scription as documented in actual medication lists, resident
characteristics (age, sex, length of stay at DSCU, and diagnosis
of dementia according to the patient’s physician using DSM-
IV criteria) as documented in patient’s charts, and institutional
characteristics (nurse/resident ratio, number of residents per
DSCU, and number of different caregivers) as reported by the
DSCU’s team leader). All other data were collected web-based
as completed per nurse or physician. For description of the
population of physicians and nurses, we also asked them for
their age and sex.
Statistical analyses
We conducted both univariate and multivariate multilevel
logistic regression analyses with the prescription of APs, ADs,
anxiolytics, and hypnotics separately as dependent variables.
For the univariate analyses, variables were individually used
as ﬁxed effects, with the levels nursing home location and
DSCU as random intercepts. In the multivariate modeling, we
entered all independent variables per cluster for each of the
ﬁve aforementioned clusters into a unilevel logistic regression
model and applied stepward backward likelihood ratio selec-
tion with entry p < 0.05, removal p < 0.10, classiﬁcation cut-
off 0.5, and maximum 20 iterations. This resulted in a prese-
lected set of resident-related and four sets of non-resident-
related factors (Mindset, and so on). Then, all variables from
the ﬁve preselected sets were put together in a multilevel
(resident within DSCU) logistic regression model.
In order to assess the robustness of our ﬁndings, we inves-
tigated whether and to which extent the ﬁve alternative path-
ways for selecting variables into the ﬁnal models led to
different results: (1) without analyzing the cluster of resident-
related factors; this was done to explore their inﬂuence, (2) by
adding the clusters in a sequential order: ﬁrst resident-related
factors, then Mindset, Knowledge and experience, and so on,
since the factors in the clusters earlier in this chain are
thought to have a more direct inﬂuence than those of the
clusters later in this chain, (3) by using physicians instead of
DSCU as level in model 2, to investigate if the selection
depended on the level of clustering, (4) by applying model 2
as a 3-level model (residents within DSCUs within nursing
home locations), to investigate whether locations explained
part of the variation, and (5) by entering the clusters in revised
sequential order as applied in 4.
We used the Nagelkerke R2 of the logistic regression mod-
els to estimate the amount of variance in PD prescription
explained by the resident- and non-resident-related variables,
and we used Pearson correlations to check for multicollinear-
ity between severity and emotional distress of NPS. For all
analyses, we used SPSS 22.0 (IBM, Armonk, NY).
Results
Prevalence rates
Participants were 559 residents, 25 physicians, and 112
nurses, distributed over 12 long-term care organizations, 21
nursing home locations, and 44 DSCUs, located throughout
the Netherlands. Thirty-three percent of the residents had a
chart diagnosis of Alzheimer’s dementia, 17% of vascular
dementia, 11% of mixed Alzheimer’s/vascular dementia, and
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39% of other/not otherwise speciﬁed dementia. Characteris-
tics of the participants are shown in Table 2. Prevalence of PD
prescription was 56% for any PD, 25% for APs, 29% for ADs,
15% for anxiolytics, and 13% for hypnotics. Ranges varied: for
any PD from 43% to 75% per nursing home location and from
33% to 88% per DSCU (see Table 3).
Correlates
This paragraph describes the factors with statistically signiﬁ-
cant associations in both univariate and multivariate analyses
according to the main model. The latter are also presented in
Table 4. Full results are shown in the Appendices.
Resident-related factors
AP prescription was signiﬁcantly more likely in the univariate
analyses for residents with lower age, male sex, and more
severe NPS (NPI-Q psychosis, agitation, depression, anxiety,
nighttime behavior, and CMAI physical aggression, physically
nonaggressive behavior, and verbally agitated behavior). In
the multivariate model, AP prescription was more likely for
longer stays at the DSCU and more severe NPS (CMAI physical
aggression and physically nonaggressive behavior). Odds of
AD prescription were higher in univariate analyses with more
severe NPS (NPI-Q psychosis, agitation, depression and
anxiety, and CMAI physical aggression and verbally agitated
behavior). Anxiolytics prescription was more likely in the uni-
variate analyses for residents with more severe NPS (NPI-Q
anxiety and nighttime behavior, and CMAI physically nonag-
gressive behavior), and in the multivariate analyses with more
severe NPS (NPI-Q anxiety). Hypnotics prescription was more
likely in the univariate analyses for residents with more severe
NPS (NPI-Q nighttime behavior and CMAI physically nonag-
gressive behavior).
Non-resident-related factors
From the Mindset cluster, the odds of AP prescription were
higher in the univariate analyses with higher emotional dis-
tress in nurses due to NPS (NPI-Q psychosis, agitation, depres-
sion, anxiety, and nighttime behavior). AD prescription was
more likely in the univariate analyses with higher emotional
distress due to NPS (NPI-Q agitation, depression, and anxiety),
and in the multivariate analyses with higher nurses’ satisfac-
tion of patient contact (MAS-GZ). Odds of anxiolytics prescrip-
tion were higher with higher emotional distress due to NPS
(NPI-Q psychosis, agitation, anxiety, and nighttime behavior)
in the univariate analyses. Hypnotics prescription was more
likely with higher emotional distress due to NPS (NPI-Q night-
time behavior) in the univariate analyses.
From the clusters Knowledge and experience and Communi-
cation and cooperation, none of the factors showed statisti-
cally signiﬁcant relations, whereas from the External
possibilities/limitations cluster, the multivariate analyses
showed that AP prescription was less likely with a higher
availability of the physicians.
Table 2. Characteristics of study participants.
a. Characteristics of nursing home residents (N = 559)
Mean age (years), [SD] (range) 84, [6.6] (62–100)
Sex, female N (%) 413 (74%)
Diagnosis of dementia, N (%)
Alzheimer’s dementia 186 (33%)
Vascular dementia 92 (17%)
Mixed Alzheimer’s/vascular dementia 62 (11%)
Other dementia 219 (39%)
Length of stay at DSCU (months), [SD] (range) 23, [22.1] (0–118)
b. Characteristics of physicians (N = 25)
Mean age (years), [SD] (range) 46, [11.2] (29–65)
Sex, female N (valid %) 16 (67%)
Current position, N (valid %)
Elderly care physician 19 (79%)
Other physician 5 (21%)
Mean number of months working at DSCU, [SD] (range) 40, [29.3] (3–99)
Mean number of years working as physician, [SD]
(range)
19, [12.3] (2–42)
c. Characteristics of nurses (N = 112)
Mean age (years), [SD] (range) 43, [10.4] (22–61)
Sex, female N (valid %) 106 (98%)
Profession, N (valid %)
Nursing assistant 10 (9%)
Certiﬁed nursing assistant 72 (67%)
Registered nurse 26 (24%)
Mean number of years working experience at current
DSCU [SD] (range)
6.4, [6.3] (0–35)
SD: standard deviation, DSCU: dementia special care unit.






Psychotropics 311 (56%) 9.0 (43%–75%) 13.1 (33%–88%)
Antipsychotics 141 (25%) 14.5 (10%–57%) 18.2 (0%–62%)
Antidepressants 163 (29%) 11.5 (12%–56%) 15.4 (0%–75%)
Anxiolytics 85 (15%) 7.9 (0%–31%) 12.8 (0%–60%)
Hypnotics 74 (13%) 8.3 (0%–27%) 11.9 (0%–45%)
DSCU: dementia special care unit.
Table 4. Resident- and non-resident-related factors of psychotropic drug pre-
scription in multivariate multilevel logistic regression analyses in 559 nursing
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AP: antipsychotics, AD: antidepressants, OR: odds ratio, CI: conﬁdence inter-
val, DSCU: dementia special care unit, NPI-Q S: Neuropsychiatric Inventory
Questionnaire Severity, CMAI: Cohen-Mansﬁeld Agitation Inventory, MAS-
GZ: Maastricht Work Satisfaction Scale for Healthcare. Ranges: 0–3 for NPI-
Q S anxiety, 8–56 for CMAI physical aggression, 7–49 for CMAI physically
nonaggressive behavior, 1–5 for MAS-GZ. Only factors with statistically
signiﬁcant ORs are shown, full results are presented in the appendices.
ORs are rounded on two decimal places, statistical signiﬁcance is based
upon the crude numbers.
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Other results
Analysis results of the ﬁve alternative multivariate models
were fairly consistent, with two exceptions for models 2 and
3: hypnotics prescription was less likely with a higher satisfac-
tion of clarity regarding tasks in the job and with higher work
stress.
The Nagelkerke R2 showed that resident-related factors
explained 6%–15% of the variance; resident-related and non-
resident-related factors together explained 8%–17%. The total
explained variance varied per class of PD: it was higher for AP
and hypnotics (respectively 17% and 13%) than for AD and
anxiolytics (both 8%).
The Pearson correlations between NPI-Q severity clusters/
symptoms and their corresponding emotional distress NPI-Q
clusters/symptoms were: 0.81 for psychosis, 0.84 for agitation,
0.78 for depression, 0.83 for anxiety, and 0.77 for nighttime
behavior.
Discussion
This study provides the latest Dutch PD prescription rates and
is also the ﬁrst exploratory study that quantitatively addresses
the association of psychosocial non-resident-related factors
with PD prescription. We found a relative absence of statisti-
cally signiﬁcant associations, regardless of the statistical
modeling strategy and class of PDs, and a very limited contri-
bution to the explained variance, whereas the prevalence
rates per nursing home location and DSCU varied consider-
ably. These ﬁndings indicate that further improvement of PD
prescription is very well possible.
Comparing the prevalence rates in our population with the
worldwide ranges shown in the introduction, it appears that
the prescription rate of APs in our sample is rather average,
whereas our rates are relatively low for ADs, anxiolytics, and
hypnotics (De Mauleon et al., 2014; Dutcher et al., 2014; Zui-
dema et al., 2011). When we add our ﬁgures to a recent analy-
sis of trends in Dutch PD use, we can conclude that the
prevalence of PDs in general, ADs, anxiolytics, and hypnotics
is rather similar and constant over time, whereas AP prescrip-
tion declines (Zuidema, Koopmans, Schols, Achterberg, & Her-
togh, 2015). Regarding the correlates, only a few can be
compared with previous literature, since most factors have
not been studied before. We found that higher emotional dis-
tress in nurses due to NPS is related with higher odds of all
classes of PD prescription, which is in line with a previous
study (Zuidema et al., 2011). Furthermore, just as Azermai,
Elseviers, Petrovic, Van Bortel, and Vander Stichele (2011), we
did not ﬁnd any relations for nurse/residents ratio whereas
others did (Kim & Whall, 2006; Zuidema et al., 2011). The
absence of a relation with the nurses’ profession is fairly in
line with the absence found regarding nurses’ educational
level in the aforementioned study (Azermai et al., 2011). And
although several publications suggest that organizational cul-
ture might inﬂuence prescription behavior (Hughes, Lapane,
Watson, & Davies, 2007; Tjia, Gurwitz, & Briesacher, 2012; Van
Der Putten, Wetzels, Bor, Zuidema, & Koopmans, 2014), our
results did not conﬁrm this.
Strengths of this study are that we could extend and
deeply explore quantitatively the ﬁndings of the qualitative
part of the PROPER I study, with a substantial number of resi-
dents and nursing home locations throughout the Nether-
lands. The main limitation is that we had too many variables
for conﬁrmatory analyses. On theoretical grounds, there was
no reason to exclude any of those, which we tried to over-
come by clustering the variables. The concordance between
the results of the uni- and multivariate analyses, in which var-
iables were studied independently by correcting for all other
variables, adds to the conﬁdence that the clustering did not
affect the ﬁndings. Also, the choice for the levels in the multi-
variate analyses (e.g. physician instead of DSCU) did not
affect the outcome, concluding from the fairly consistent
results over the multiple statistical approaches. Finally, since
we chose for a cross-sectional instead of a longitudinal
design for feasibility reasons, we could not draw conclusions
on causal relations.
For interpretation of associations with non-resident-related
factors, four subjects require comment. First, it is striking that
the two statistically signiﬁcant associations in the multivariate
analyses with non-resident-related factors both concern the
contact between the nursing home professional and the resi-
dent. Although we have to be cautious not to overrate their
relevance considering the number of associations that we
studied, the contribution of interpersonal contact in PD pre-
scription may be an important starting point for further
research. Second, the strong correlation between the NPI-Q’s
emotional distress and severity might on one hand indicate
that the nurses’ view of severity was colored by personally
perceived distress, or by emotional distress just upon scoring
severity. This weakness of the NPI-Q, as of its mother version
the NPI, is known (Kaufer et al., 1998; Kaufer et al., 2000), and
may have diluted a potential stronger contribution of either
the resident-related NPI severity or the non-resident-related
Mindset factor NPI distress. On the other hand, the correlation
between NPI severity and distress may as well implicate that
NPS were so far erroneously identiﬁed as the determinant,
meaning that nurses’ distress due to NPS might just as well
be the main contributor to PD prescription. Third, it may be
interesting to differentiate between the theoretical possibili-
ties to operationalize the qualitative themes. Operationaliza-
tion of the factors within the clusters Mindset and
Communication and cooperation and part of those within
External possibilities/limitations into measurable variables is
rather complex. A questionnaire may not be able to comprise
these psychosocial concepts, social interactions within and
between groups of people cannot be reduced to one-on-one
relations, and evaluating a number of variables may be insufﬁ-
cient to unravel the reality. In contrast, this complexity is less
applicable for the quantiﬁable measures among the External
possibilities/limitations (physician’s availability per resident,
number of residents per DSCU, nurse/resident ratios, and the
number of different caregivers). The absence of signiﬁcant
associations of these quantiﬁable variables is a stronger indi-
cation that those are not likely to contribute to PD prescrip-
tion. Fourth, the wide ranges in prescription rates between
different locations and DSCUs, and the large unexplained vari-
ance illustrate that the complexity of PD prescribing is yet not
unraveled.
Tentatively interpreting these exploratory ﬁndings for
clinical practice, it is important to be aware of the possibly
limited extent to which PD prescription can be affected by
non-resident-related factors. Future studies may therefore
focus on associations with so far unstudied resident-related
factors. Nevertheless, the fact that NPS were found to be the
strongest correlates suggests that clinical practice should at
least target NPS, after all being the indication for PD
prescription.
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Conclusion
AP prescription in this study is lower than in previous Dutch
studies, but the large differences between locations and units
leave room for further improvement. Prescription rates of
ADs, anxiolytics, and hypnotics are comparable with the rates
of previous Dutch studies but are internationally rather low.
Although this study has some limitations, we investigated
many non-resident-related factors meticulously. The relative
absence of signiﬁcant associations suggests that improve-
ment of PD prescribing could provisionally best be targeted
at resident-related factors.
The low prescription rates in the international perspective
and the prescription rates of AP declining over time suggest
that especially AP prescription is improving, although the
large differences in prevalence rates between locations and
units leave room for enhancement.
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Appendices
Appendix 1. Resident-related factors of psychotropic drug prescription in univariate and multivariate
multilevel logistic regression analyses in 559 nursing home residents with dementia.
Appendix 2. Non-resident-related factors of psychotropic drug prescription in univariate and multivariate









Univariate Multivariate Univariate Multivariate Univariate Multivariate Univariate Multivariate
Age of resident 0.96 (0.94–0.99) 0.97 (0.94–1.00) 0.97 (0.95–1.00) – 0.98 (0.94–1.01) – 0.97 (0.94–1.01) –
Sex of resident
Male 1.59 (1.03–2.46) – 0.96 (0.63–1.46) – 0.98 (0.58–1.67) – 1.33 (0.77–2.28) –
Female (ref)
Length of stay at DSCU 1.01 (1.00–1.01) 1.01 (1.00–1.02) 1.00 (0.99–1.01) – 1.00 (0.99–1.01) – 0.99 (0.98–1.00) –
Dementia type
Alzheimer’s dementia 1.31 (0.81–2.12) – 1.20 (0.77–1.85) – 0.89 (0.51–1.57) – 1.10 (0.61–1.95) –
Vascular dementia 1.30 (0.73–2.34) – 1.14 (0.66–1.96) – 1.09 (0.56–2.13) – 1.08 (0.53–2.21) –
Mixed Alzheimer’s
/vascular dementia
1.53 (0.79–2.96) – 0.88 (0.46–1.68) – 1.37 (0.66–2.86) – 0.56 (0.21–1.54) –
Other dementia (ref)
NPI-Q S psychosis 1.21 (1.08–1.35) – 1.19 (1.07–1.33) – 1.12 (0.99–1.27) – 1.05 (0.91–1.21) –
NPI-Q S agitation 1.18 (1.09–1.26) – 1.10 (1.02–1.17) 1.07 (1.00–1.15) 1.07 (0.98–1.16) – 1.05 (0.96–1.15) –
NPI-Q S depression 1.27 (1.05–1.54) – 1.43 (1.20–1.71) 1.19 (0.90–1.58) 1.14 (0.91–1.42) – 1.12 (0.88–1.42) –
NPI-Q S anxiety 1.22 (1.01–1.48) – 1.24 (1.04–1.48) – 1.61 (1.32–1.97) 1.64 (1.16–2.30) 1.23 (0.98–1.54) –
NPI-Q S nighttime behavior 1.25 (1.00–1.56) – 1.13 (0.91–1.40) – 1.39 (1.09–1.79) – 1.62 (1.25–2.09) 1.51 (1.00–2.28)
CMAI physical aggression 1.07 (1.04–1.11) 1.05 (1.00–1.09) 1.03 (1.00–1.06) – 1.03 (1.00–1.07) – 0.99 (0.94–1.03) –
CMAI physically
nonaggressive behavior
1.07 (1.04–1.10) 1.06 (1.03–1.09) 1.02 (1.00–1.05) – 1.05 (1.02–1.08) – 1.06 (1.03–1.10) –
CMAI verbally agitated
behavior
1.04 (1.01–1.08) – 1.04 (1.01–1.08) – 1.03 (1.00–1.08) – 1.00 (0.95–1.04) –
OR: odds ratio, CI: conﬁdence interval, DSCU: dementia special care unit, NPI-Q S: Neuropsychiatric Inventory Questionnaire Severity clusters/symptoms, CMAI: Cohen-Mansﬁeld Agita-
tion Inventory – long form. Ranges: 0–6 for NPI-Q S psychosis, 0–9 for NPI-Q S agitation, 0–3 for NPI-Q S depression, 0–3 for NPI-Q S anxiety, 0–3 for NPI-Q S nighttime behavior, 8–
56 for CMAI physical aggression, 7–49 for CMAI physically nonaggressive behavior, and 4–28 for CMAI verbally agitated behavior. Blank cells represent variables not entered in the
multivariate models, and bold/grey shading indicates statistical signiﬁcance. The criterion to select variables was p < 0.10. For a description of precision of the selected variables,
95% CI are presented. ORs are rounded on two decimal places, statistical signiﬁcance is based upon the crude numbers.


















NPI-Q E psychosis 1.16 (1.04–1.29) – 1.09 (0.99–1.21) – 1.16 (1.04–1.31) – 1.00 (0.87–1.16) –
NPI-Q E agitation 1.15 (1.08–1.23) 1.05 (0.96–1.14) 1.08 (1.02–1.15) – 1.08 (1.01–1.16) – 1.01 (0.92–1.09) –
NPI-Q E
depression
1.31 (1.09–1.56) – 1.42 (1.20–1.67) 1.19 (0.92–1.55) 1.18 (0.96–1.44) – 1.01 (0.80–1.28) –
NPI-Q E anxiety 1.25 (1.05–1.49) – 1.22 (1.04–1.44) – 1.43 (1.19–1.72) 0.98 (0.72–1.35) 1.11 (0.89–1.38) –
NPI-Q E nighttime
behavior
1.34 (1.10–1.64) – 1.18 (0.97–1.44) – 1.42 (1.15–1.76) – 1.44 (1.14–1.80) 1.07 (0.74–1.54)
SDCS 0.99 (0.82–1.19) – 1.06 (0.90–1.24) – 1.01 (0.83–1.22) – 1.03 (0.83–1.28) –
MAS-GZ resident
contact
1.24 (0.77–1.99) 1.44 (0.97–2.15) 1.50 (1.00–2.25) 0.87 (0.54–1.41) – 1.00 (0.57–1.77) –
ADQ (physician) 0.98 (0.91–1.06) 1.01 (0.94–1.08) 0.99 (0.93–1.04) – 0.99 (0.94–1.05) – 0.94 (0.88–1.00) 0.98 (0.91–1.06)





0.59 (0.23–1.55) – 0.89 (0.39–2.00) – 1.02 (0.38–2.72) – 0.54 (0.17–1.73) –
Certiﬁed
nursing assistant



















1.12 (0.69–1.81) – 1.09 (0.72–1.65) – 0.87 (0.53–1.42) – 0.94 (0.54–1.66) –
MAS-GZ clarity 1.30 (0.75–2.28) 1.40 (0.78–2.52) 0.83 (0.53–1.31) – 0.98 (0.58–1.65) – 0.77 (0.43–1.41) –
External possibilities/limitations
Work stress scale 1.02 (0.67–1.56) – 1.04 (0.73–1.48) – 1.14 (0.75–1.73) – 0.77 (0.46–1.27) –
CVFS clan culture 0.98 (0.91–1.05) – 1.01 (0.95–1.06) – 1.01 (0.95–1.08) 0.90 (0.80–1.00) 1.07 (0.98–1.17) 0.93 (0.83–1.05)
(continued)
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1.01 (0.92–1.11) – 1.05 (0.97–1.14) – 0.95 (0.87–1.04) 0.90 (0.80–1.01) 0.96 (0.87–1.07) 0.91 (0.77–1.08)
CVFS hierarchy
culture
0.99 (0.91–1.08) – 0.96 (0.89–1.04) – 1.03 (0.94–1.12) – 1.00 (0.90–1.10) 0.89 (0.74–1.08)
CVFS market
culture




















1.00 (0.97–1.03) – 0.99 (0.97–1.01) – 1.00 (0.97–1.02) – 0.98 (0.95–1.01) –
OR: odds ratio, CI: conﬁdence interval, NPI-Q E: Neuropsychiatric Inventory Questionnaire Emotional distress clusters/symptoms (range 0–10 for psychosis, 0–15 for agitation, 0–5 for
depression, for anxiety, and for nighttime behavior), SDCS: Strain in Dementia Care Scale (range 1–16), MAS-GZ: Maastricht Work Satisfaction Scale for Healthcare (range 1–5 for
each subscale), ADQ: Approaches to Dementia Questionnaire (range 19–95), DSCU: dementia special care unit, CVFS: Competing Values Framework Scale (range 0–18). The work
stress scale ranges from 1 to 5. Blank cells represent variables not entered in the multivariate models, and bold/grey shading indicates statistical signiﬁcance. The criterion to select
variables was p < 0.10. For a description of precision of the selected variables, 95% CI are presented. ORs are rounded on two decimal places, statistical signiﬁcance is based upon
the crude numbers.
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